Clinical Trial Update: Study of DCR-A1AT in Healthy Adult Volunteers [Phase 1]

View source ↗

Summary

Phase 1 trial of DCR-A1AT in healthy adult volunteers has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alpha-1 Antitrypsin Deficiency

Drugs mentioned

• DCR-A1AT (DCR-A1AT)

Snippet

Sponsor: Dicerna Pharmaceuticals, Inc., a Novo Nordisk company | Conditions: Alpha 1-Antitrypsin Deficiency | Phase 1 | Status: COMPLETED